Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Stanley Black & Decker
SWK
$15.5B
| $777K | ﹤0.01% |
9,673
+1,188
| +14% | +$110K |
|
1677
Aspen Aerogels
ASPN
$419M
| $769K | ﹤0.01% |
64,700
-85,932
| -57% | -$1.46M |
|
|
DVAX
1678
DELISTED
Dynavax Technologies
DVAX
| $763K | ﹤0.01% |
59,777
-8,247
| -12% | -$99.8K |
|
1679
Vera Therapeutics
VERA
$2.15B
| $762K | ﹤0.01% |
18,018
-2,053
| -10% | -$90.9K |
|
1680
Southern California Bancorp
BCAL
$693M
| $760K | ﹤0.01% |
45,963
| – | – |
|
|
TSVT
1681
DELISTED
2seventy bio
TSVT
| $754K | ﹤0.01% |
256,569
-5,471
| -2% | -$22.4K |
|
1682
PUT
Ovintiv
OVV
$16.8B
| $749K | ﹤0.01% |
2,560
| – | – |
|
1683
Heron Therapeutics
HRTX
$96.8M
| $747K | ﹤0.01% |
488,122
-8,105
| -2% | -$13.1K |
|
1684
Revvity
RVTY
$12.4B
| $743K | ﹤0.01% |
6,655
+776
| +13% | +$91.2K |
|
1685
Atea Pharmaceuticals
AVIR
$376M
| $732K | ﹤0.01% |
218,509
-3,053
| -1% | -$10.1K |
|
1686
SIGA Technologies
SIGA
$232M
| $723K | ﹤0.01% |
120,225
+8,028
| +7% | +$53.7K |
|
1687
Mine Safety
MSA
$7.45B
| $721K | ﹤0.01% |
4,351
-274
| -6% | -$47K |
|
1688
Summit Therapeutics
SMMT
$11B
| $716K | ﹤0.01% |
40,119
-4,069
| -9% | -$78.9K |
|
1689
American Financial Group
AFG
$11.7B
| $692K | ﹤0.01% |
5,052
+164
| +3% | +$22.6K |
|
1690
Arcutis Biotherapeutics
ARQT
$3.26B
| $686K | ﹤0.01% |
49,267
-3,882
| -7% | -$42.5K |
|
1691
Toast
TOST
$19.6B
| $674K | ﹤0.01% |
18,498
-13,822
| -43% | -$486K |
|
1692
BioCryst Pharmaceuticals
BCRX
$2.29B
| $670K | ﹤0.01% |
89,057
-18,763
| -17% | -$142K |
|
1693
D.R. Horton
DHI
$42.1B
| $669K | ﹤0.01% |
4,787
-38,949
| -89% | -$6.51M |
|
1694
Hafnia
HAFN
$3.72B
| $668K | ﹤0.01% |
+119,989
| New | +$712K |
|
1695
Clorox
CLX
$12.7B
| $662K | ﹤0.01% |
4,074
+646
| +19% | +$106K |
|
1696
East-West Bancorp
EWBC
$18.3B
| $661K | ﹤0.01% |
6,899
-11,079
| -62% | -$1.09M |
|
1697
Amphastar Pharmaceuticals
AMPH
$877M
| $660K | ﹤0.01% |
17,784
-1,939
| -10% | -$88.7K |
|
1698
Roku
ROKU
$21.9B
| $660K | ﹤0.01% |
8,877
-248
| -3% | -$18.8K |
|
1699
Hormel Foods
HRL
$13.9B
| $659K | ﹤0.01% |
+21,016
| New | +$659K |
|
1700
Anika Therapeutics
ANIK
$262M
| $655K | ﹤0.01% |
39,785
+1,407
| +4% | +$27.8K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.